United States:
December Issue Of The Bio/Pharma Beat Is Now Available!
16 December 2019
Squire Patton Boggs LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Our monthly newsletter reports on the patent law developments in
biotech, biologics and pharmaceutical cases, legislation and
federal agency actions. This month's issue covers relevant news from November 2019,
including:
- Federal Circuit affirms the Patent
Trial and Appeal Board's ("PTAB")'s application
of the "blocking patent" doctrine as applied to objective
indicia of non-obviousness
- District court orders production of
privileged documents reviewed by a Rule 30(b)(6) witness in
preparation for her deposition
- More patent-busting draft legislation
in the US Senate
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.
